Spyre Therapeutics
SYRE
#4930
Rank
S$1.89 B
Marketcap
$32.33
Share price
3.16%
Change (1 day)
34.29%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2024 (TTM): -$97.84

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$97.81. In 2023 the company made an earnings per share (EPS) of -$66.56 a decrease over its 2022 EPS that were of -$33.54.

EPS history for Spyre Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$97.8446.99%
2023-$66.5698.46%
2022-$33.54-1%
2021-$33.88-34.21%
2020-$51.49-37.96%
2019-$82.9915.02%
2018-$72.1518.33%
2017-$60.98-18.92%
2016-$75.20120.2%
2015-$34.15-33.55%
2014-$51.39